Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

Wegovy, a semaglutide injection, aids in weight loss by suppressing appetite and boosting metabolism, now available in South ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

Wegovy contains semaglutide ... Health News // 1 week ago FDA approves weight-loss drug Zepbound to treat sleep apnea Dec. 21 (UPI) -- Zepbound, the new GLP-1 weight-loss drug from Eli Lilly ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

Wegovy, meanwhile, earned its own landmark nod earlier in 2024, when it became the first weight-loss med approved to reduce ...

Starting in the new year, the region’s largest health insurer will no longer cover popular diabetes drugs for the purposes of ...

The move comes as weight-loss medications have garnered immense ... an anti-obesity medication a bit wider than when the FDA approved Wegovy for cardiovascular disease risk reduction early in ...

Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to ... in a class of its own as the only FDA-approved dual GIP and GLP-1 receptor ...

Both Ozempic, made by Novo Nordisk, and Mounjaro, made by Eli Lilly, are FDA-approved to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.